Over 60 per cent of the fixed-dose combination (FDC) drugs used for treating mental health disorders in India are 'unapproved' and lack proven therapeutic value, the study found
The controversy arose after the central govt issued a notification on March 10 pursuant to the Doctor Kokate panel report banning 344 Fixed Dose Combination drugs
